HTLV-I uveitis

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue SUPPL. 1, 1996, Pages

  Mochizuki, Manabu ^a   Ono, Ayako ^a   Ikeda, Eiko ^a   Hikita, Naofumi ^a   Watanabe, Toshiki ^b   Yamaguchi, Kazunari ^c   Sagawa, Kimitaka ^a   Ito, Kyogo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

HTLV I; Uveitis

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

CELL INFILTRATION; CONFERENCE PAPER; CORTICOSTEROID THERAPY; GENE EXPRESSION; HUMAN T CELL LEUKEMIA VIRUS 1; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RETINA; UVEITIS; VASCULITIS; VIRUS PARTICLE;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0029769606     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199600001-00010     Document Type: Conference Paper

References (22)

1. Blattner WA. Epidemiology of HTLV-I and associated diseases. In: Blattner WA, ed. Human retrovirology: HTLV. New York: Raven, 1990:251-65.
2. Tajima K, Hinuma Y. Epidemiology of HTLV-I/II in Japan and the world. In: Takatsuki K, Hinuma Y, Yoshida M, eds. Advances in adult T-cell leukemia and HTLV-I research. Tokyo: Japan Scientific Societies, 1992:129-49.
3. Poiesz BJ, Ruscetti FW, Gazder AF, Bunn PA, Minna PA, Gallo EG. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of patients with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77:7415-9.
4. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 1984;81:2534-7.
5. Gessain A, Barin F, Vernant JC, Gout O, Calender A, de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2: 407-10.
6. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy: a new clinical entity. Lancet 1986;1:1031-2.
7. Yamaguchi K. Human T-lymphotropic virus type I in Japan. Lancet 1994;343:213-6.
8. Mochizuki M, Yamaguchi K, Takatsuki K, Watanabe T, Mori S, Tajima K. HTLV-I and uveitis. Lancet 1992;339: 1110.
9. Ikeda E, Wada K, Yoshimura K, Mochizuki M. Statistics of uveitis in northern and southern districts in Kushu. Jpn J Clin Ophthalmol 1993;47:1267-70.
10. Ohba N, Matsumoto M, Sameshima M, et al. Ocular manifestation in patients infected with human T-lymphotropic virus type 1. Jpn J Ophthalmol 1989;33:1-12.
11. Sasaki K, Morooka I, Inomata H, Kashio N, Akamine T, Osame M. Retinal vasculitis in human T-lymphotropic virus type I associated myelopathy. Br J Ophthalmol 1989;73: 812-5.
12. Mochizuki M, Watanabe T, Yamaguchi K, et al. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 1992;83:236-9.
13. Mochizuki M, Watanabe T, Yamaguchi K, et al. Uveitis associated with human T lymphotropic virus type I: seroepidemiological, clinical, and virological studies. J Infect Dis 1992;166:943-4.
14. Mochizuki M, Watanabe T, Yamaguchi K, et al. Uveitis associated with human T-cell lymphotropic virus type I. Am J Ophthalmol 1992;114:123-9.
15. Yoshimura K, Mochizuki M, Araki S, Miyata N, Yamaguchi K, Tajima K, Watanabe T. Clinical and immunological features of human T-cell lymphotropic virus type I uveitis. Am J Ophthalmol 1993;116:156-63.
16. Sugimoto S, Mita S, Tokunaga M, et al. Pulmonary involvement in human T-cell lymphotropic virus type-I uveitis: T-lymphocytosis and high proviral DNA load in bronchoalveolar lavage fluid. Eur Respir J 1993;6:938-43.
17. Ono A, Miura T, Araki S, et al. Subtype analysis of HTLV-I in patients with HTLV-I uveitis. Jpn J Cancer Res 1994;85: 767-70.
18. Yamaguchi K, Mochizuki M, Watanabe T, et al. Human T lymphotropic virus type 1 uveitis after Graves disease. Br J Ophthalmol 1994;78:163-6.
19. Yamaguchi K, Kiyokawa T, Watanabe T, et al. Increased serum levels of C-terminal parathyroid hormone-related protein in different diseases associated with HTLV-I infection. Leukemia 1994;8:1708-11.
20. Ono A, Mochizuki M, Yamaguchi K, Miyata N, Watanabe T. Increased number of circulating HTLV-I infected cells in peripheral blood mononuclear cells of HTLV-I uveitis patients: a quantitative polymerase chain reaction study. Br J Ophthalmol 1995;79:270-6.
21. Masuoka K, Sagawa K, Mochizuki M, Oizumi K, Itoh K. Polyclonal use of T-cell receptor for human T-cell lymphotropic virus type 1-infected T cells. Invest Ophthalmol Vis Sci 1995;36:254-8.
22. Sagawa K, Mochizuki M, Masuoka K, et al. Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis: detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production. J Clin Invest 1995;95:852-8.